MM Update 4/17/08
Posted by Eve on April 28, 2008
Molecular Targets Enhance Chemotherapy in Multiple Myeloma: http://www.newswise.com/articles/view/539806/
Immunomedics’ Milatuzumab May Enhance Efficacies of Therapeutics for Multiple Myeloma in Preclinical Studies: http://www.primenewswire.com/newsroom/news.html?d=140072
Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting: http://www.newswire.ca/en/releases/archive/April2008/15/c5802.html
New health service for dioxin victims launched: http://www.stuff.co.nz/4483213a20475.html
Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research: http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-16-2008/0004793869&EDATE=
Geron Presentations at the AACR 2008 Annual Meeting: http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20080416005314&newsLang=en
Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR: http://www.earthtimes.org/articles/show/kosan-presents-preclinical-data-on,355511.shtml
Cancer Drug Maker Sees Growth Potential In Europe And Beyond: http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-24557771.htm
Stemming the tumorous tide: http://www.economist.com/science/displaystory.cfm?story_id=11043891
